title: Oncogenes in human testicular cancer: DNA and RNA studies.
abstract: Oncogene dosage and expression were studied in 16 testicular neoplasms, 14 of germ cell and two of non-germ cell origin. In comparison with normal DNA, tumour DNA of a total of eight patients (seven with germ cell neoplasm and one with testicular lymphoma) showed increased dosages of KRAS2, PDGFA, EGFR, MET and PDGFB. The most frequent (occurring in six tumours) and prominent (up to 3-4-fold) increases were detected in the dosages of KRAS2 (on chromosome 12p) and PDGFA (chromosome 7p), relative to a reference locus from chromosome 2. Importantly, there was a similar increase in 12p dosage in general in these tumours, suggesting the presence of the characteristic isochromosome 12p marker. On the contrary, possible 7p polysomy (assessed by molecular methods) did not explain the PDGFA (or EGFR) changes in all cases. NRAS, MYCN, CSFIR, MYB, MYC, ABL, HRASI, TP53, and ERBB2 did not reveal any consistent alterations in tumour DNA. In RNA dot blot assays the expression of KRAS2, PDGFA, EGFR, or MYC was generally not increased in the tumour samples when compared to that in normal testicular tissue of the same patients although there was interindividual variation in mRNA levels. It thus appears that while oncogene dosage changes occur in a proportion of testis cancers, they are often part of changes in large chromosomal regions or whole arms and are seldom accompanied by altered expression.
authors.affiliation: Department of Medical Genetics, University of Helsinki, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Peltomäki
authors.forename: O
authors.initials: O
authors.lastname: Alfthan
authors.forename: A
authors.initials: A
authors.lastname: de la Chapelle
mesh_terms: D000199:Actins / Q000235:genetics; D015342:DNA Probes; D004273:DNA, Neoplasm / Q000097:blood / Q000235:genetics* / Q000302:isolation & purification; D066246:ErbB Receptors / Q000235:genetics; D006801:Humans; D008297:Male; D015513:Oncogene Proteins / Q000235:genetics; D009857:Oncogenes; D010982:Platelet-Derived Growth Factor / Q000235:genetics; D012334:RNA, Neoplasm / Q000097:blood / Q000235:genetics / Q000302:isolation & purification; D013736:Testicular Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology
chemical_list: D000199:Actins; D015342:DNA Probes; D004273:DNA, Neoplasm; D015513:Oncogene Proteins; D010982:Platelet-Derived Growth Factor; D012334:RNA, Neoplasm; D066246:ErbB Receptors